EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte StudieMultizentrische Studie

A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia

Andrew Dauber, Ravi Savarirayan, Philippe M Campeau, Ricki S Carroll, Moira Cheung, Valérie Cormier-Daire, Josep Maria de Bergua, Thomas Edouard, Michaela Veronika Gonfiantini, Julie Hoover-Fong, Peter Kannu, Yutaka Kinoshita und 18 weitere

NEJM Evidence · 27.10.2026 · 5 (11)

DOI: 10.1056/evidoa2600257 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift NEJM Evidence, erschienen am 27.10.2026. Verfasst von Andrew Dauber und 29 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Children's National Hospital, Washington, DC, USA. Hauptthemen laut MEDLINE: Bone and Bones, Dwarfism, Limb Deformities, Congenital, Lordosis. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone and BonesDwarfismLimb Deformities, CongenitalLordosisNatriuretic Peptide, C-TypeAdolescentChildChild, PreschoolFemaleHumansMaleDouble-Blind MethodInjections, SubcutaneousTreatment Outcome

Substanzen

Natriuretic Peptide, C-Typevosoritide

Autor:innen und Institutionen

  • Division of Endocrinology, Children's National Hospital, Washington, DC, USA.
  • Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
  • Molecular Therapies, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Royal Children's Hospital, Parkville, VIC, Australia.
  • Department of Pediatrics, University of Melbourne, Parkville, VIC, Australia.
  • Centre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, QC, Canada.

Zitieren

APA

Dauber, A., Savarirayan, R., Campeau, P. M., Carroll, R. S., Cheung, M., Cormier-Daire, V., de Bergua, J. M., Edouard, T., Gonfiantini, M. V., Hoover-Fong, J., Kannu, P., Kinoshita, Y., Kubota, T., Mendoza-Londono, R., Namba, N., Ohata, Y., Onesimo, R., Palm, K., Prada, C. E., …, & Maghnie, M. (2026). A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia. NEJM Evidence, 5(11). https://doi.org/10.1056/evidoa2600257

Vancouver

Dauber A, Savarirayan R, Campeau PM, Carroll RS, Cheung M, Cormier-Daire V, et al. A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia. NEJM Evidence. 2026;5(11). doi:10.1056/evidoa2600257

BibTeX
@article{Dauber2026,
  author = {Dauber, Andrew and Savarirayan, Ravi and Campeau, Philippe M and Carroll, Ricki S and Cheung, Moira and Cormier-Daire, Valérie and de Bergua, Josep Maria and Edouard, Thomas and Gonfiantini, Michaela Veronika and Hoover-Fong, Julie and Kannu, Peter and Kinoshita, Yutaka and Kubota, Takuo and Mendoza-Londono, Roberto and Namba, Noriyuki and Ohata, Yasuhisa and Onesimo, Roberta and Palm, Katja and Prada, Carlos E and Reynaud, Rachel and Rossi, Massimiliano and Semler, Oliver and Takasawa, Kei and Bassi, Roberto and Ghani, Sajda and Huntsman Labed, Alice and Osmond, Dane and Sabir, Ian and White, Jeanette and Maghnie, Mohamad},
  title = {A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia},
  journal = {NEJM Evidence},
  year = {2026},
  volume = {5},
  number = {11},
  doi = {10.1056/evidoa2600257}
}
Kostenlos starten →